Members
The Neuroscience Working Table consists of stakeholders, including patient groups, manufacturers, providers, and researchers, with a common interest in advancing legislative reforms to foster development in neuroscience.
The Neuroscience Working Table brings together technical expertise, real world experience, regulatory knowledge, public policy understanding, and government affairs expertise to develop and drive a consensus proposal to achieve this goal.
AbbVie
Acadia Pharmaceuticals
Alkermes
Alliance for Aging Research
Alliance for Patient Access
The ALS Association
The American Academy of Neurology
American Brain Coalition
American Psychiatric Association
Autism Speaks
Avanir Pharmaceuticals
Cerevel Therapeutics
Coalition for Headache and Migraine Patients
CurePSP
Depression and Bipolar Support Alliance
Eisai Inc.
Epilepsy Foundation
FasterCures
The Headache & Migraine Policy Forum
I AM ALS
Intra-Cellular Therapies
Johnson & Johnson
Karuna Therapeutics
The Kennedy Forum
LEAD Coalition (Leaders Engaged on Alzheimer’s Disease)
Lewy Body Dementia Association
Lundbeck Pharmaceuticals, LLC
Mental Health America
Michael J. Fox Foundation for Parkinson’s Research
The Multiple System Atrophy (MSA) Coalition
National Alliance on Mental Illness
National Down Syndrome Society
National MS Society
Neurocrine Biosciences
Otsuka
One Mind
Parkinson’s Foundation
Sage Therapeutics
Schizophrenia and Psychosis Action Alliance
Sunovion Pharmaceuticals
Takeda
UsAgainstAlzheimer’s
U.S. Pain Foundation
Vradenburg Foundation